/
Even if we obtain regulatory approval to market our product candidates, the availability and price of our competitors products could limit the demand and the price we are able to charge for our product candidates. We may not be able to implement our business plan if the acceptance of our product candidates is inhibited by price competition or the reluctance of physicians to switch from existing…
The business is unprofitable at the operating level (-17.66% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 10.4% YoY with margins expanding 98.8pp.
Negative free cash flow of -$77M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$124M
▲ +10.4% YoY
Net Income (TTM)
$65M
▲ +100.0% YoY
Op. Margin
6.62%
▲ +98.8pp YoY
ROIC
9.83%
▲ +80.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$88M
▲ +51.4% YoY
Op. Cash Flow (TTM)
-$88M
▲ +51.2% YoY
Net Debt
$36M
Cash & Equiv.
$35M
5Y CAGR: +5.3%
Continue Research